Today, Bristol Laboratories is among the leading suppliers of quality pharmaceuticals products in the United Kingdom, with in-house product development expertise that ensures the addition of newer generic products to the pipeline every year.
Our ambition is to be a leading player in the global pharmaceutical industry. Therefore our business development strategies are focused on the expansion of our generic product portfolio, development of a wide range of over the counter (OTC) products and increasing our generic footprint across the world.
Our business development unit constantly seeks to synergise our in-house capabilities through the acquisition of newer products and niche technologies, as well as to collaborate on product development, strategic partnerships and alliances across the globe.